CD4 and neoplasm: In this study, breast cancer patients had significantly reduced levels of CD3 + T cells, CD4 + T cells, CD4 + /CD8 + ratio, and NK cells, confirming that the transition of a tumor from benign to malignant can lead to significant immunosuppression.